Spine Wave Launches True Position Pivoting Spacer
Spine Wave commenced full U.S. market launch of the True Position® Pivoting Spacer. Jul 11, 2016
Graftys Granted U.S. Patent for Highly-osteogenic Biomaterial
Graftys was granted U.S. Patent No. 13/923,577, covering GRFT-R02 highly-osteogenic biomaterial for use in bone tissue regeneration. Jul 11, 2016
Corin Orthopaedics to Acquire Wright Medical’s Hip and Knee Assets
Wright Medical received a binding offer under which Corin Orthopaedics would acquire Wright’s hip/knee business for 29.7MM in cash (~US $33MM). The proposed transaction is expected to close by early 4Q16. Jul 11, 2016
Additive Orthopaedics Treats Hammertoes with 3D-Printed Implants
Additive Orthopaedics announced successful treatment of a series of hammertoe cases with its 3D-printed implant. Jul 07, 2016
Interim U.S. Study Results: ConforMIS’ iTotal CR
Interim results from a U.S. 300+ patient multi-center prospective study of ConforMIS’ iTotal CR total knee indicate that 92% of patients were satisfied with their procedures at one year. Jul 06, 2016
Preclinical Study Validates Science Behind AlloSource AlloStem Cellular Bone Allograft
Preclinical data on adipose-derived mesenchymal stem cells in a rat model, using technology similar to AlloSource’s AlloStem® Cellular Bone Allograft process, showed bone formation within a critical-sized defect in all study subjects. Jul 06, 2016
Merit Medical Acquires DFINE
Merit Medical Systems, manufacturer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, acquired DFINE in a merger transaction for ~US $97.5MM in cash. Jul 06, 2016
First Implantation of Camber Spine’s Enza Zero-Profile ALIF Device
Camber Spine Technologies announced the first implantation of the ENZA™ MIS Zero-Profile ALIF device, occuring in a 2-level lumbar procedure. Jul 06, 2016
Two-year Clinical Results for Spineart’s Baguera C Cervical Disc
Study results indicate that patients treated with Spineart’s BAGUERA® C cervical disc in 1- or 2-level arthroplasty exhibited good mobility at treated and adjacent levels, disc height restoration and evidence of adjacent level preservation. Jul 06, 2016
Amedica Prices $11 Million Public Offering
Amedica priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions. Closing is expected to occur by 7/8/16. Jul 05, 2016
